Clik here to view.
BioJapan 2014 World Business Forum Exhibitor Profiles
YOKOHAMA, Japan BioJapan 2014 World Business Forum takes place October 15 – 17 at the PACIFICO YOKOHAMA in Yokohama, Japan. Business Wire is the official media partner for the BioJapan 2014....
View ArticleClik here to view.
【 BioJapan 】 － アジア最大級のバイオ総合展 －世界のバイオ企業が日本に熱視線！ビッグファーマ・ベンチャー・アカデミアが創る新バイオビジネス
東京 （ビジネスワイヤ） — 来る2014年10月15日（水）～17日（金）の3日間、パシフィコ横浜の展示ホールC・Dとアネックスホール全館においてBioJapan 2014 – World Business Forum – を開催します。 BioJapan...
View ArticleClik here to view.
DNA Sequencing HPV Testing and Pap Smears Necessary for Optimum Patient Care,...
MILFORD, Conn. Sin Hang Lee, M.D., a Milford (Conn.) Hospital pathologist and lead author of “From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice,” a...
View ArticleClik here to view.
Spain VHIR Selects Macrogen as the Genomics Service Partner
BARCELONA, Spain & SEOUL, South Korea The Vall d’Hebron Research Institute (VHIR, www.vhir.org) in Barcelona, Spain, and the world-leading Genomics services company Macrogen (www.macrogen.com)...
View ArticleClik here to view.
Macrogen Introduces Latest Service Portfolio and Presents Research Outcome at...
SAN DIEGO, Calif. & SEOUL, South Korea The integrated genomic service provider, Macrogen (www.macrogen.com) (KRX 038290) has announced its plans to launch new service portfolio and hold an...
View ArticleClik here to view.
Personalis and the Garvan Institute Announce Commercial Partnership for Whole...
MENLO PARK, Calif. & SYDNEY Personalis, Inc., a leading genomics-based clinical research and diagnostics global service provider based in the USA, and the Garvan Institute of Medical Research in...
View ArticleClik here to view.
Macrogen Selects GenoLogics’ Clarity LIMS to Strengthen X-Genome and Clinical...
SEOUL, South Korea & SAN FRANCISCO The personalized medicine biotechnology company Macrogen (www.macrogen.com) has announced it has licensed Clarity LIMS from GenoLogics Life Sciences Software...
View ArticleClik here to view.
マクロジェンがX-Genomeサービスおよび臨床シーケンシングサービスを強化するためジェノロジックスのClarity LIMSを選定
韓国ソウル & サンフランシスコ （ビジネスワイヤ） — 個別化治療薬バイオテクノロジー企業のマクロジェン（www.macrogen.com）は、オミックス・ラボ専用にデザインされたLIMSの大手プロバイダーであるジェノロジックス・ライフ・サイエンシズ・ソフトウエア（www.genologics.com）より、Clarity...
View ArticleClik here to view.
Macrogen选择GenoLogics的Clarity LIMS来加强X基因组和临床测序服务
韩国首尔和旧金山 (美国商业资讯)–个体化医学生物技术公司Macrogen (www.macrogen.com)宣布，已从GenoLogics Life Sciences Software (www.genologics.com)获得Clarity LIMS的授权，以支持其全基因组测序和临床测序服务，GenoLogics是专为基因组学实验室设计的LIMS的领先提供商。...
View ArticleClik here to view.
Enigma Diagnostics Signs Joint Venture Agreement with Beijing Leadman...
SALISBURY, England & BEIJING Enigma Diagnostics Ltd (Enigma), a global leader in molecular diagnostic point-of-care (PoC) infectious disease testing, and Beijing Leadman Biochemistry Co., Ltd....
View ArticleClik here to view.
Enigma Diagnostics与北京利德曼生化股份有限公司签署合资协议，并宣布一项5000万美元的投资
英格兰索尔兹伯里和北京 (美国商业资讯) — 分子诊断床边(point-of-care)感染性疾病检测的全球领先者Enigma Diagnostics Ltd (Enigma)与北京利德曼生化股份有限公司（Beijing Leadman Biochemistry Co.,...
View ArticleClik here to view.
Akebia Announces Positive Top-Line Results from its Phase 2b Study of...
CAMBRIDGE, Mass. Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia...
View ArticleClik here to view.
Transgenomic and University of Melbourne Collaborate to Further Validate...
OMAHA, Neb. Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and...
View ArticleClik here to view.
Akebiaが慢性腎臓病に関連した貧血を伴う非透析患者を対象にAKB-6548を検討した第2b相試験で、優れて良好な結果が得られたと発表
米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 低酸素誘導因子（HIF）の生物学を通じて腎臓病患者に革新的治療薬を提供することに傾注するバイオ製薬企業のAkebia Therapeutics,...
View ArticleClik here to view.
Takeda Announces Abstracts for ADCETRIS® (brentuximab vedotin) in Hodgkin...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that abstracts of interest from studies on VELCADE® (bortezomib), ADCETRIS® (brentuximab vedotin)...
View ArticleClik here to view.
武田宣布，ADCETRIS® (brentuximab...
马萨诸塞州坎布里奇和日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502)今天宣布，该公司关注的VELCADE® （硼替佐米）、ADCETRIS® (brentuximab vedotin)和研究中的口服蛋白酶体抑制剂ixazomib...
View ArticleClik here to view.
Renowned Japanese Scholar Takashi Gojobori Receives Honorary Doctorate from NCKU
TAINAN, Taiwan Dr. Takashi Gojobori, a world-renowned expert on molecular evolution and comparative genomics, received an honorary doctoral degree from National Cheng Kung University (NCKU),...
View ArticleClik here to view.
株式会社東芝が日本で新たに開始するゲノム解析サービスのためにアフィメトリクス社のAxiomプラットフォームを採用
カリフォルニア州サンタクララ発 （ビジネスワイヤ） — アフィメトリクス社（NASDAQ：AFFX）は、株式会社東芝（TYO：6502）ヘルスケア社が新たに開始するゲノム解析サービスのプラットフォームとして、Axiom®ジェノタイピングソリューションが採用されたことを発表します。当社は、株式会社東芝と協働し、Axiomプラットフォーム技術を用いて｢ジャポニカアレイ®...
View ArticleClik here to view.
Toshiba Corporation Selects Affymetrix Axiom Platform for Its Newly Launched...
SANTA CLARA, Calif. Affymetrix (NASDAQ: AFFX) announces its Axiom® Genotyping Solution platform has been selected by Toshiba Corporation’s (TYO: 6502) Healthcare Company as the platform for its...
View ArticleClik here to view.
HanAll Biopharma Co., Ltd. and Open Monoclonal Technology Announce Collaboration
SEOUL, South Korea & PALO ALTO, Calif. HanAll BioPharma Co., Ltd. (HanAll), a public Korean biopharmaceutical company and leader in development of novel biologics and new chemical entities in...
View Article